Brief resolved unexplained event: Difference between revisions
Ostermayer (talk | contribs) |
No edit summary |
||
| Line 3: | Line 3: | ||
*ALTE is a symptom, not a dx | *ALTE is a symptom, not a dx | ||
*Only 10% have repeat events | *Only 10% have repeat events | ||
*ALTE is not related to SIDS | *ALTE is not related to [[SIDS]] | ||
== | === Risk Factors === | ||
*Episode that is frightening to caregiver and involves combination of: | *RSV infection | ||
*Prematurity | |||
*Recent anesthesia | |||
*GERD | |||
*Airway/maxillofacial anomalies | |||
*Age < 10 wks | |||
*Hx of apneas | |||
*Pallor, cyanosis, feeding difficulties | |||
== Clinical Features == | |||
Episode that is frightening to caregiver and involves combination of: | |||
*Apnea | |||
*Color change | |||
*Muscle tone change | |||
*Choking or gagging | |||
==History== | ==History== | ||
| Line 27: | Line 37: | ||
**Medication use | **Medication use | ||
== | == Differential Diagnosis<ref>McGovern MC. et al. Smith MB. Causes of apparent life threatening events in children: a systemic review. Arch Dis Child. 2004;89(11):1043-1048</ref> == | ||
===Common<ref>Okada K et al. Discharge Diagnoses in infants with apparent life threatening event admissions and gastroesophageal reflux disease. Pediatric Emergency Care. 2012;28(1):17-21</ref>=== | ===Common<ref>Okada K et al. Discharge Diagnoses in infants with apparent life threatening event admissions and gastroesophageal reflux disease. Pediatric Emergency Care. 2012;28(1):17-21</ref>=== | ||
*Idiopathic (~50%) | |||
*GERD | |||
*Seizure | |||
*Respiratory tract infection | |||
*Misinterpretation of benign process (e.g. periodic breathing) | |||
*Vomiting/choking episode | |||
===Less Common=== | ===Less Common=== | ||
*Pertussis | |||
*Inflicted injury | |||
*Poisoning | |||
*Serious bacterial infection | |||
**Must consider in all febrile pts with ALTE | |||
*Electrolyte abnormality (incl glucose) | |||
===Uncommon=== | ===Uncommon=== | ||
*Arrhythmia | |||
*[[Anemia]] | |||
*Breath-holding spell (6mo - 4yrs) | |||
*Metabolic disease | |||
== Work-Up == | == Work-Up == | ||
(Individualize testing by history and exam) | (Individualize testing by history and exam) | ||
*CBC | |||
*Chem 10 | |||
*UA | |||
*CXR | |||
*Pertussis nasal swab | |||
*RSV nasal swab | |||
*Consider: | |||
**UCx/BC | |||
**ECG | |||
**LP | |||
**LFTs | |||
**MRI Brain | |||
== Management == | == Management == | ||
*Stable patients without a clear diagnosis | |||
**No evidence-based guidelines for proper w/u dispo decision | |||
*Stable patients with a clear diagnosis | |||
**Manage according to identified disease | |||
===Empiric Treatment for Unstable Patients=== | ===Empiric Treatment for Unstable Patients=== | ||
{| cellspacing="1" cellpadding="3" border="0" bgcolor=" | {| cellspacing="1" cellpadding="3" border="0" bgcolor="*666666" width="100%" | ||
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | ||
! valign="top" bgcolor=" | ! valign="top" bgcolor="*ffffff" align="left" rowspan="0" | Medication/Intervention | ||
! valign="top" bgcolor=" | ! valign="top" bgcolor="*ffffff" align="left" rowspan="0" | Indication | ||
! valign="top" bgcolor=" | ! valign="top" bgcolor="*ffffff" align="left" rowspan="0" | Dose/Size (for neonate) | ||
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | ||
| valign="top" bgcolor=" | | valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Glucose | ||
| valign="top" bgcolor=" | | valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Hypoglycemia | ||
| valign="top" bgcolor=" | | valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 5–10 mL/kg of 10% dextrose in water IV | ||
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | ||
| valign="top" bgcolor=" | | valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 3% normal saline | ||
| valign="top" bgcolor=" | | valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Symptomatic hyponatremia | ||
| valign="top" bgcolor=" | | valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 3–5 mL/kg bolus IV | ||
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | ||
| valign="top" bgcolor=" | | valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Calcium | ||
| valign="top" bgcolor=" | | valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Hypocalcemia | ||
| valign="top" bgcolor=" | | valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 50–100 milligrams/kg calcium gluconate or 20 milligrams/kg calcium chloride IV | ||
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | ||
| valign="top" bgcolor=" | | valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Cefotaxime | ||
| valign="top" bgcolor=" | | valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Infection | ||
| valign="top" bgcolor=" | | valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 50 milligrams/kg IV | ||
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | ||
| valign="top" bgcolor=" | | valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Ampicillin | ||
| valign="top" bgcolor=" | | valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Infection | ||
| valign="top" bgcolor=" | | valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 50 milligrams/kg IV | ||
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | ||
| valign="top" bgcolor=" | | valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Packed red blood cells | ||
| valign="top" bgcolor=" | | valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Anemia | ||
| valign="top" bgcolor=" | | valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 10 mL/kg IV | ||
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | ||
| valign="top" bgcolor=" | | valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Normal saline | ||
| valign="top" bgcolor=" | | valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Hypotension, dehydration | ||
| valign="top" bgcolor=" | | valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 20 mL/kg IV | ||
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | ||
| valign="top" bgcolor=" | | valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 10% dextrose in one fourth normal saline | ||
| valign="top" bgcolor=" | | valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Metabolic disease | ||
| valign="top" bgcolor=" | | valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 1.5 maintenance (6 mL/kg/h for the first 10 kg) | ||
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | ||
| valign="top" bgcolor=" | | valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Endotracheal intubation | ||
| valign="top" bgcolor=" | | valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Hypoventilation or frequent apnea | ||
| valign="top" bgcolor=" | | valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | <span class="Apple-style-span" style="font-size: 12px; ">3mm for preemie; 3mm for term neonate, 4mm</span><span class="Apple-style-span" style="font-size: 10px;"> </span>for older infant | ||
|} | |} | ||
| Line 131: | Line 131: | ||
Especially for: | Especially for: | ||
*<48wk postconceptual age | |||
*Ill-appearing | |||
*Bronchiolitis or pertussis w/ apnea | |||
*>1 event in past 24hr or multiple ALTEs | |||
*Abnormalities in PMH | |||
*Prolonged central apnea >20s | |||
*ALTE requiring resus | |||
*Family history of SIDS | |||
==Current Research== | ==Current Research== | ||
| Line 145: | Line 145: | ||
*300 Infants in a single center with 76% admission rate with 37 (12%) required significant intervention | *300 Infants in a single center with 76% admission rate with 37 (12%) required significant intervention | ||
;Predictors for requiring intervention | ;Predictors for requiring intervention | ||
*Prematurity | |||
*Abnormal physical examination | |||
*Color change to cyanosis, | |||
*Absence of upper respiratory infection symptoms and the absence of choking | |||
*Negative predictive value: 96% | *Negative predictive value: 96% | ||
*Specificity of 70.5% | *Specificity of 70.5% | ||
| Line 156: | Line 156: | ||
*832 patients from 4 different study sites, with a 79.2% admission rate | *832 patients from 4 different study sites, with a 79.2% admission rate | ||
;Predictors for requiring admission | ;Predictors for requiring admission | ||
*Obvious need for admission: | |||
**Supplemental Oxygen requirement | |||
**Resuscitation | |||
**Hemodynamic Instability | |||
**Positive RSV or Pertussis test | |||
*Significant past medical history | |||
**Congenital heart disease | |||
**Down Syndrome | |||
**Previous Intubation | |||
*Chromosomal abnormaility | |||
*Chronic Lung Disease | |||
* > 1 ALTE in 24 hours | |||
*Negative predictive value of 96.5% | *Negative predictive value of 96.5% | ||
*Sensitivity of 89% , a Specificity of 61.9% , and a calculated | *Sensitivity of 89% , a Specificity of 61.9% , and a calculated | ||
Revision as of 11:37, 12 May 2015
Background
- Peak incidence: 1wk - 2mo
- ALTE is a symptom, not a dx
- Only 10% have repeat events
- ALTE is not related to SIDS
Risk Factors
- RSV infection
- Prematurity
- Recent anesthesia
- GERD
- Airway/maxillofacial anomalies
- Age < 10 wks
- Hx of apneas
- Pallor, cyanosis, feeding difficulties
Clinical Features
Episode that is frightening to caregiver and involves combination of:
- Apnea
- Color change
- Muscle tone change
- Choking or gagging
History
- PMH
- Prematurity, history of apnea, prior resp/feeding difficulties
- Immunization status (pertussis)
- FH
- History of SIDS, cardiac, seizure, metabolic disease
- Event
- Duration, resus required
- Temporal relationship with feeding, sleeping, crying, vomiting, choking
- Central versus obstructive pattern of apnea
- Episodic versus sustained change in mental status
- ROS
- Respiratory symptoms
- Medication use
Differential Diagnosis[1]
Common[2]
- Idiopathic (~50%)
- GERD
- Seizure
- Respiratory tract infection
- Misinterpretation of benign process (e.g. periodic breathing)
- Vomiting/choking episode
Less Common
- Pertussis
- Inflicted injury
- Poisoning
- Serious bacterial infection
- Must consider in all febrile pts with ALTE
- Electrolyte abnormality (incl glucose)
Uncommon
- Arrhythmia
- Anemia
- Breath-holding spell (6mo - 4yrs)
- Metabolic disease
Work-Up
(Individualize testing by history and exam)
- CBC
- Chem 10
- UA
- CXR
- Pertussis nasal swab
- RSV nasal swab
- Consider:
- UCx/BC
- ECG
- LP
- LFTs
- MRI Brain
Management
- Stable patients without a clear diagnosis
- No evidence-based guidelines for proper w/u dispo decision
- Stable patients with a clear diagnosis
- Manage according to identified disease
Empiric Treatment for Unstable Patients
| Medication/Intervention | Indication | Dose/Size (for neonate) |
|---|---|---|
| Glucose | Hypoglycemia | 5–10 mL/kg of 10% dextrose in water IV |
| 3% normal saline | Symptomatic hyponatremia | 3–5 mL/kg bolus IV |
| Calcium | Hypocalcemia | 50–100 milligrams/kg calcium gluconate or 20 milligrams/kg calcium chloride IV |
| Cefotaxime | Infection | 50 milligrams/kg IV |
| Ampicillin | Infection | 50 milligrams/kg IV |
| Packed red blood cells | Anemia | 10 mL/kg IV |
| Normal saline | Hypotension, dehydration | 20 mL/kg IV |
| 10% dextrose in one fourth normal saline | Metabolic disease | 1.5 maintenance (6 mL/kg/h for the first 10 kg) |
| Endotracheal intubation | Hypoventilation or frequent apnea | 3mm for preemie; 3mm for term neonate, 4mm for older infant |
Disposition
Admission in most cases
Especially for:
- <48wk postconceptual age
- Ill-appearing
- Bronchiolitis or pertussis w/ apnea
- >1 event in past 24hr or multiple ALTEs
- Abnormalities in PMH
- Prolonged central apnea >20s
- ALTE requiring resus
- Family history of SIDS
Current Research
- Neither of these decision rules have been validated
Mittal ALTE Decision Rule[3]
- 300 Infants in a single center with 76% admission rate with 37 (12%) required significant intervention
- Predictors for requiring intervention
- Prematurity
- Abnormal physical examination
- Color change to cyanosis,
- Absence of upper respiratory infection symptoms and the absence of choking
- Negative predictive value: 96%
- Specificity of 70.5%
- 7 out of the 184 (3.8%) were incorrectly discharged
Kaji ALTE Decision Rule[4]
- 832 patients from 4 different study sites, with a 79.2% admission rate
- Predictors for requiring admission
- Obvious need for admission:
- Supplemental Oxygen requirement
- Resuscitation
- Hemodynamic Instability
- Positive RSV or Pertussis test
- Significant past medical history
- Congenital heart disease
- Down Syndrome
- Previous Intubation
- Chromosomal abnormaility
- Chronic Lung Disease
- > 1 ALTE in 24 hours
- Negative predictive value of 96.5%
- Sensitivity of 89% , a Specificity of 61.9% , and a calculated
- 14 (2%) patients were incorrectly discharged
Sources
- Fu L. et al. Apparent Life-threatening events: an update. Pediatr Rev. 2012; 33(8(:361-368
- Tieder J et al. Management of apparent life-threatening events: a systemic review. J Pediatr. 2013 Jul;163(1):94-9
- ↑ McGovern MC. et al. Smith MB. Causes of apparent life threatening events in children: a systemic review. Arch Dis Child. 2004;89(11):1043-1048
- ↑ Okada K et al. Discharge Diagnoses in infants with apparent life threatening event admissions and gastroesophageal reflux disease. Pediatric Emergency Care. 2012;28(1):17-21
- ↑ Mittal M. et al. A clinical decision rule to identify infants with apparent life-threatening events who can be safely discharged from the emergency department. Pediatric Emergency Care. 2012;28(7): 599-605
- ↑ Kaji A et al. Apparent life-threatening event: multicenter prospective cohort study to develop a clinical decision rule for admission to the hospital. Ann Emerg Med. 2013;61(4):379-387
